Stephens & Co. Reiterates Overweight on Arvinas, Maintains $18 Price Target

Arvinas, Inc.

Arvinas, Inc.

ARVN

0.00

Stephens & Co. analyst Sudan Loganathan reiterates Arvinas (NASDAQ: ARVN) with a Overweight and maintains $18 price target.